Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies is a dataset published in Cancer Cell (2022). On theSindex it has a DataRank of 4.9, placing it in the top 4.3% of the data-sharing corpus. It has been cited 329 times, with 100 citing works in its 1-hop citation network.
Ranks in the top 4% for downstream scientific impact
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.870
From this paper's citation signal
Citation Network Contribution
4.1
From 100 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
National Institutes of Health
Grant: 28XS197 P-0518835
NCI NIH HHS
Grant: U54 CA209891
National Institutes of Health
Grant: PO1-CA210961
NCI NIH HHS
Grant: R01 CA255442
National Human Genome Research Institute
Grant: U54-HG007990
Gateway for Cancer Research
Grant: G-20-600
Gateway for Cancer Research
Grant: G-16-900
NCI NIH HHS
Grant: P01 CA210961
NCI NIH HHS
Grant: P30 CA082103
BCRF
Grant: BCRF-20-165
NCI NIH HHS
Grant: P30 CA016672
NCATS NIH HHS
Grant: UL1 TR001863
National Institutes of Health
Grant: / NCI I-SPY2+
NCI NIH HHS
Grant: U01 CA225427
NHGRI NIH HHS
Grant: U54 HG007990
AstraZeneca
Seattle Genetics
Boehringer Ingelheim
George Mason University
GlaxoSmithKline
Amgen
Daiichi-Sankyo
Stand Up To Cancer
University of California, San Francisco
Genentech
Pfizer
Merck
Samsung
AbbVie
Foundation for the National Institutes of Health
Puma Biotechnology
FWCI
23.72
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals